Cartesian Pauses Lupus And Multiple Myeloma Studies As It Shifts Development Focus

Why did Walmart’s CEO announce retirement? How did Disney and YouTube TV end blackout? Why did Trump cut tariffs on food imports? What caused Bitcoin’s recent price drop? How is Berkshire Hathaway shifting tech investments? Why is Nvidia’s stock facing scrutiny? What impact will Google’s new data centers have?

Cartesian Pauses Lupus And Multiple Myeloma Studies As It Shifts Development Focus

benzinga.com/news/health-care/25/11/48873824/cartesian-pauses-lupus-and-multiple-myeloma-studies-as-it-shifts-development-focus

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) on Friday shared initial data from the ongoing Phase 2 open-label trial of Descartes-08, its lead cell therapy candidate, for systemic lupus erythematosus (SLE).
SLE is a chronic autoimmune disease where the body’s immune system attacks healthy…

This story appeared on benzinga.com, 2025-11-14 18:02:38.